CALY Antibodies

AND CALY ELISA kits, CALY Proteins

Many biological assays use antibodies to detect CALY, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with CALY in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop CALY antibodies...

We validate the specificity of these antibodies to CALY by testing them on tissues known to express CALY positively and negatively. Browse below to find the CALY antibody that suites your experiment. We have 2 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: SEPTIN9 Next: ANO7

CALY Infographic by Boster Bio

All CALY Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

Anti-CALY Antibody

Human, Mouse, Rat

$405
Cat # A08000
100ul

Calcyon (CALY) (NM_015722) Human Over-expression Lysate

Human

$628
Cat # LS050632
100 µg

CALY Overview

Facts about Neuron-specific vesicular protein calcyon.

CALY 3D structure. Source: alphafold

Neuron-specific vesicular protein calcyon (CALY)

Interacts with clathrin light chain A and stimulates clathrin self-assembly and clathrin-mediated endocytosis. .

Gene Information

Human
Gene Name:	CALY
Uniprot:	Q9NYX4
Entrez:	50632

Family

Belongs to:

NSG family

Alternative Names

calcyon D1 dopamine receptor-interacting protein (CALCYON); calcyon neuron-specific vesicular protein; DRD1IP

Molecular Weight

Mass (kDA):
23.434 kDA

Genomic Context


Human

Location:	10q26.3
Sequence:	10; NC_000010.11 (133324072..133336896, complement)

Tissue Specificity

Expressed in the pyramidal cells of the prefrontal cortex, in hippothalamus and in caudate nucleus. No expression in spleen. Up-regulated in the prefrontal cortex of schizophrenic patients with nearly twice the levels of non- schizophrenics.